Skinvisible, Inc. (SKVI)
OTCMKTS: SKVI · Delayed Price · USD
0.101
+0.039 (62.64%)
May 10, 2024, 3:58 PM EDT - Market closed

Company Description

Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas.

Its non-dermatological formulations offer solutions for women's health, pain management, and other markets.

The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions.

The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999.

Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.

Skinvisible, Inc.
Country NV
Founded 1998
IPO Date Jan 7, 1999
Industry Household & Personal Products
Sector Consumer Staples
Employees 2
CEO Terry H. Howlett

Contact Details

Address:
6320 S Sandhill Road, Unit 9
Las Vegas, Nevada 89120
United States
Phone 702-433-7154
Website skinvisible.com

Stock Details

Ticker Symbol SKVI
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001085277
CUSIP Number 830703203
ISIN Number US8307032032
Employer ID 88-0344219
SIC Code 2834

Key Executives

Name Position
Terry H. Howlett President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Director
Doreen McMorran Head of Business Development

Latest SEC Filings

Date Type Title
May 15, 2024 10-Q Quarterly Report
Apr 16, 2024 10-K Annual Report
Apr 1, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Nov 15, 2023 10-Q Quarterly Report
Nov 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Oct 25, 2023 8-K Current Report
Aug 14, 2023 10-Q Quarterly Report
May 10, 2023 10-Q Quarterly Report
Mar 30, 2023 10-K Annual Report
Nov 14, 2022 10-Q Quarterly Report